CAC
IRWD icon

Cowen and Company’s Ironwood Pharmaceuticals IRWD Stock Holding History

Cowen and Company’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-900,000
Closed -$45K – 670
2024
Q1 		$45K Buy
+900,000
New +$10.9M ﹤0.01% 359
2021
Q1 		– Sell
-10,000
Closed -$4K – 585
2020
Q4 		$4K Buy
+10,000
New +$109K ﹤0.01% 366

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Cowen and Company's IRWD Position: Q1 2024 in Review

Cowen and Company sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2024, closing a stake of 200,578 shares — an estimated $2.43M sold.

Cowen and Company first reported a position in IRWD in Q4 2023 and held it in 1 quarter. The position peaked at $2.29M in Q4 2023. 261 funds tracked by Wall St. Rank hold IRWD as of Q1 2024.

  • Cowen and Company reported no remaining Ironwood Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Cowen and Company sold 200,578 Ironwood Pharmaceuticals shares in Q1 2024, an estimated $2.43M.
  • Cowen and Company first reported a position in Ironwood Pharmaceuticals in Q4 2023 and held it in 1 quarter.
  • Cowen and Company's Ironwood Pharmaceuticals position peaked at $2.29M in Q4 2023.
  • 261 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2024.

Based on Cowen and Company's 13F filing for Q1 2024, filed 3 May 2024.